Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bc0744a9cfce7e8a299dbb40d362ec1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
filingDate |
2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5073461e6991f5c3e0b5889e6e16d29d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f74011da42e0806ae961ed4bbd6d6b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bdad588411c2cd09dcef7bda03d2a99 |
publicationDate |
2020-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2020147128-A1 |
titleOfInvention |
Use of lithium ascorbate to prevent and treat alcoholism and alcohol intoxication |
abstract |
The invention relates to medicine, particularly to the chemical and pharmaceutical industry and more particularly to the use of lithium ascorbate, in a dose of at least 5 mg/kg, as an agent for preventing and treating alcoholism and alcohol intoxication, and also providing protection of brain neurons and reducing demyelinating complications. The invention makes it possible to broaden the range of agents for this purpose. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2738564-C1 |
priorityDate |
2017-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |